Tina Susan Nova
CIK 1302605 · Executive Chairperson · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.00M
Companies
9
Total Filings
82
Lifetime Open-Market Net
-$10.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Director | — | $15.82 | — | $0 | 2 | 2026-06-08 |
| AZTA | Director | 15,772 | $22.59 | $356.3K | $0 | 4 | 2026-02-06 |
| XGN | Executive Chairperson | — | $4.67 | — | $0 | 7 | 2025-06-12 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Director | 0 | $99.99 | $0 | -$1.23M | 18 | 2022-03-11 |
| VCYT | President, CLIA U.S. | 76,988 | $47.33 | $3.64M | $0 | 8 | 2022-03-07 |
| OPGEN INC (OPGNW) Delisted | Director | 750 | — | — | $0 | 4 | 2019-09-03 |
| GENOPTIX INC (GXDX) Delisted | President and CEO | 25 | — | — | -$8.95M | 29 | 2011-03-07 |
| CYPRESS BIOSCIENCE INC (CYPB) Delisted | Director | — | — | — | $0 | 1 | 2010-01-06 |
| CYPRESS BIOSCIENCE INC (NSTR) Delisted | Director | — | — | — | $0 | 4 | 2009-01-07 |
Recent Filings · Page 8 of 9
82 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-02-05 | GENOPTIX INC (GXDX) Delisted | Mixed | — | -$617.8K | EDGAR |
| 2009-01-08 | GENOPTIX INC (GXDX) Delisted | Mixed | — | -$567.0K | EDGAR |
| 2009-01-07 | CYPRESS BIOSCIENCE INC (NSTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-05 | GENOPTIX INC (GXDX) Delisted | Mixed | +16,624 | -$137.2K | EDGAR |
| 2008-04-14 | GENOPTIX INC (GXDX) Delisted | Grant (A) | +33,100 | $0 | EDGAR |
| 2008-03-06 | GENOPTIX INC (GXDX) Delisted | Sell (S) | −118,212 | -$3.01M | EDGAR |
| 2008-03-05 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-03 | GENOPTIX INC (GXDX) Delisted | Exer (M) | +117,542 | $66.8K | EDGAR |
| 2008-01-29 | CYPRESS BIOSCIENCE INC (NSTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-01-04 | CYPRESS BIOSCIENCE INC (NSTR) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.